Antibody

1,020개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,020 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleGilead SciencesPhase 2

the doxorubicin conjugate of milatuzumab (hLL1-DOX, hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Gilead
Trials 1Status Discontinued
AntibodyLimited DatastaleSuZhou Stainwei Biotech Inc.Phase 1

hPV19 mAb (hPV19 mAb)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#monoclonal-antibody#SuZhou
Trials 1Status Active
AntibodyLimited DatastaleHawaii Pacific HealthPhase 2

ranibizumab (Lucentis, high-dose ranibizumab)

PCV; Polypoidal Choroidal Vasculopathy · PCV

#PCV#Antibody#Phase2#monoclonal-antibody#PolypoidalChoroidalVasculopathy+1
Trials 1Status Active
AntibodyLimited DatastaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#monoclonal-antibody#Gruppo
Trials 1Status Active
AntibodyLimited DatastaleUniversity Hospital, BordeauxPhase 3

immunomodulatory treatment by rituximab (immunomodulatory treatment by rituximab)

Mental Disorder · Mental Disorder

#MentalDisorder#Antibody#Phase3#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleSpectrum Pharmaceuticals, IncPhase 2

indium-111-ibritumomab tiuxetan (indium-111-ibritumomab tiuxetan)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Spectrum
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 3

injection Combined Bevacizumab and Fasudil (injection Combined Bevacizumab and Fasudil)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleJinnah Postgraduate Medical Cen…Preclinical

injection Sekucinumab (injection Sekucinumab)

Erythrodermic Psoriasis · Erythrodermic Psoriasis

#ErythrodermicPsoriasis#Antibody#Preclinical#monoclonal-antibody#Jinnah
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

injection bevacizumab (injection bevacizumab)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleShahid Beheshti University of M…Phase 3

injection of bevacizumab (injection of bevacizumab)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryDiabeticMacularEdema+1
Trials 1Status Active
AntibodyLimited DatastaleShahid Beheshti University of M…Phase 3

injection of bevacizumab and erythropoietin (injection of bevacizumab and erythropoietin)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryDiabeticMacularEdema+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

THP (investigator-selected taxane/trastuzumab/pertuzumab, investigator-selected taxane/trastuzumab/pertuzumab (THP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#NeoadjuvantTherapiesforHER2+Brea+1
Trials 1Status Active
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

iparomlimab + tuvonralimab (iparomlimab + tuvonralimab)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab +pembrolizumab +durvalumab)

Lung Cancer; Liver Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#monoclonal-antibody#LiverCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBeijing HospitalPhase 2

irinotecan, cetuximab, envafolimab (irinotecan, cetuximab, envafolimab)

RAS Mutation; Metastatic Colorectal Cancer · RAS Mutation

#RASMutation#Antibody#Phase2#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversitätsklinikum Hamburg-Ep…Phase 3

Isa-KD (isatuximab/carfilzomib/dexamethasone, isatuximab/carfilzomib/dexamethasone (Isa-KD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Universittsklinikum
Trials 1Status Discontinued
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

ivonescimab + investigator-choice platinum doublet+ (ivonescimab + investigator-choice platinum doublet+)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

ixabepilone + cetuximab (ixabepilone + cetuximab)

Triple Negative Locally Advanced Non-resectable Breast Cancer; Metastatic Breast Cancer · Triple Negative Locally Advanced Non-res

#TripleNegativeLocallyAdvancedNon#Antibody#Phase2#monoclonal-antibody#MetastaticBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleCytoDyn, Inc.Preclinical

PRO 140 (leronlimab, leronlimab (PRO 140))

TNBC; TNBC - Triple-Negative Breast Cancer · TNBC

#TNBC#Antibody#Preclinical#monoclonal-antibody#TNBC-Triple-NegativeBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleSeagen Inc.Phase 1

lintuzumab (lintuzumab)

Myelodysplastic Syndrome (MDS) · Myelodysplastic Syndrome (MDS)

#MyelodysplasticSyndromeMDS#Antibody#Phase1#monoclonal-antibody#Seagen
Trials 1Status Active

49 / 51 pages

← PreviousNext →